Comparing recurrence rates between endoscopic mucosal resection and endoscopic submucosal dissection in Barrett’s endoscopic therapy: patient perspective matters!

Endoscopy 2025; 57(05): 571
DOI: 10.1055/a-2496-7246

Letter to the editor

Authors

Achintya D. Singh

¹Department of Gastroenterology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, United States
Lady Katherine Mejía Pérez

²Department of Gastroenterology, Cleveland Clinic, Cleveland, United States
Amit Bhatt

²Department of Gastroenterology, Cleveland Clinic, Cleveland, United States

References
1 Vantanasiri K, Iyer PG. Comparing recurrence rates between endoscopic mucosal resection and endoscopic submucosal dissection in Barrett’s endoscopic therapy: timing and definitions matter!. Endoscopy 2024;
2 Fujiyoshi Y, Khalaf K, Tham D. et al. Recurrence following successful eradication of neoplasia with endoscopic mucosal resection compared with endoscopic submucosal dissection in Barrett’s esophagus: a retrospective comparison. Endoscopy 2024;
3 Mejia Perez LK, Yang D, Draganov PV. et al. Endoscopic submucosal dissection vs. endoscopic mucosal resection for early Barrett’s neoplasia in the West: a retrospective study. Endoscopy 2022; 54: 439-446
4 Mesureur L, Deprez PH, Bisschops R. et al. Safety and efficacy of salvage endoscopic submucosal dissection for Barrett’s neoplasia recurrence after radiofrequency ablation. Endoscopy 2024; 56: 653-662